Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 285


Nucleos(t)ide Analogue Treatment for Adult Patients with HBeAg-positive Chronic Infection with Genotype C Hepatitis B Virus: A Nationwide Real-life Study.

Chang Y, Choe WH, Sinn DH, Lee JH, Ahn SH, Lee H, Shim JJ, Jun DW, Park SY, Nam JY, Cho EJ, Yu SJ, Lee DH, Lee JM, Kim YJ, Kwon SY, Paik SW, Yoon JH.

J Infect Dis. 2017 Sep 23. doi: 10.1093/infdis/jix506. [Epub ahead of print]


Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation.

Oh IS, Sinn DH, Kang TW, Lee MW, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW.

Dig Dis Sci. 2017 Oct 5. doi: 10.1007/s10620-017-4775-8. [Epub ahead of print]


Clinical importance of TERT overexpression in hepatocellular carcinoma treated with curative surgical resection in HBV endemic area.

Il Yu J, Choi C, Ha SY, Park CK, Kang SY, Joh JW, Paik SW, Kim S, Kim M, Jung SH, Park HC.

Sci Rep. 2017 Sep 25;7(1):12258. doi: 10.1038/s41598-017-12469-2.


Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: A randomized controlled trial in Korean patients with hepatitis B e antigen-negative chronic hepatitis B.

Lee KS, Kweon YO, Um SH, Kim BH, Lim YS, Paik SW, Heo J, Lee HJ, Kim DJ, Kim TH, Lee YS, Byun KS, Kim D, Lee MS, Yu K, Suh DJ.

Clin Mol Hepatol. 2017 Sep 26. doi: 10.3350/cmh.2016.0040. [Epub ahead of print]


Combination treatment with transarterial chemoembolization, radiotherapy, and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumor thrombosis: Final results of a prospective phase II trial.

Yu JI, Park HC, Jung SH, Choi C, Shin SW, Cho SK, Sinn DH, Paik YH, Gwak GY, Choi MS, Lee JH, Koh KC, Yoo BC, Sahinbas H, Paik SW.

Oncotarget. 2017 Apr 13;8(32):52651-52664. doi: 10.18632/oncotarget.17072. eCollection 2017 Aug 8.


Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: A cohort study.

Sinn DH, Kang D, Jang HR, Gu S, Cho SJ, Paik SW, Ryu S, Chang Y, Lazo M, Guallar E, Cho J, Gwak GY.

J Hepatol. 2017 Sep 20. pii: S0168-8278(17)32264-X. doi: 10.1016/j.jhep.2017.08.024. [Epub ahead of print]


Metabolically-healthy obesity is associated with higher prevalence of colorectal adenoma.

Sinn DH, Min YW, Son HJ, Rhee PL, Paik SW, Hong SN, Gwak GY.

PLoS One. 2017 Jun 21;12(6):e0179480. doi: 10.1371/journal.pone.0179480. eCollection 2017.


Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia.

Paik N, Sinn DH, Lee JH, Oh IS, Kim JH, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW.

Liver Int. 2017 Jun 5. doi: 10.1111/liv.13489. [Epub ahead of print]


[The Clinical Significance of Serum Alpha-fetoprotein in Diagnosing Hepatocellular Carcinoma in a Health Screening Population].

Ko YS, Bae JH, Sinn DH, Gwak GY, Kang W, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW.

Korean J Gastroenterol. 2017 Apr 25;69(4):232-238. doi: 10.4166/kjg.2017.69.4.232. Korean.


Proton pump inhibitors do not increase the risk for recurrent spontaneous bacterial peritonitis in patients with cirrhosis.

Kim JH, Lim KS, Min YW, Lee H, Min BH, Rhee PL, Kim JJ, Koh KC, Paik SW.

J Gastroenterol Hepatol. 2017 May;32(5):1064-1070. doi: 10.1111/jgh.13637.


Daclatasvir/Asunaprevir/Beclabuvir (DCV-TRIO), All-Oral, Fixed-Dose Combination for Patients With Chronic HCV Genotype 1.

Kao JH, Yu ML, Peng CY, Heo J, Chu CJ, Chang TT, Lee YJ, Hu TH, Yoon KT, Paik SW, Lim YS, Ahn SH, Isakov V, McPhee F, Hu W, Swenson ES, Yin PD, Treitel M.

J Gastroenterol Hepatol. 2017 Mar 31. doi: 10.1111/jgh.13796. [Epub ahead of print]


The role of scheduled second TACE in early-stage hepatocellular carcinoma with complete response to initial TACE.

Kim JH, Sinn DH, Shin SW, Cho SK, Kang W, Gwak GY, Paik YH, Lee JH, Koh KC, Paik SW, Choi MS.

Clin Mol Hepatol. 2017 Mar;23(1):42-50. doi: 10.3350/cmh.2016.0058. Epub 2017 Mar 7.


Clinical significance and predictive factors of early massive recurrence after radiofrequency ablation in patients with a single small hepatocellular carcinoma.

Cho JY, Choi MS, Lee GS, Sohn W, Ahn J, Sinn DH, Gwak GY, Paik YH, Lee JH, Koh KC, Paik SW.

Clin Mol Hepatol. 2016 Dec;22(4):477-486. doi: 10.3350/cmh.2016.0048. Epub 2016 Dec 25.


Low-level viremia and the increased risk of hepatocellular carcinoma in patients receiving entecavir treatment.

Kim JH, Sinn DH, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW.

Hepatology. 2017 Aug;66(2):335-343. doi: 10.1002/hep.28916. Epub 2016 Dec 24.


Urgency to treat patients with chronic hepatitis C in Asia.

Kao JH, Ahn SH, Chien RN, Cho M, Chuang WL, Jeong SH, Liu CH, Paik SW.

J Gastroenterol Hepatol. 2017 May;32(5):966-974. doi: 10.1111/jgh.13709. Review.


The utility of gadoxetic acid-enhanced magnetic resonance imaging in the surveillance for postoperative recurrence of hepatocellular carcinoma.

Kim JH, Min YW, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW.

Medicine (Baltimore). 2016 Dec;95(51):e5666. doi: 10.1097/MD.0000000000005666.


A Novel Model for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase Levels.

Sinn DH, Lee JH, Kim K, Ahn JH, Lee JH, Kim JH, Lee DH, Yoon JH, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW.

Gut Liver. 2017 Jul 15;11(4):528-534. doi: 10.5009/gnl16403.


Insulin resistance and the risk of hepatocellular carcinoma in chronic hepatitis B patients.

Kim JH, Sinn DH, Gwak GY, Kang W, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW.

J Gastroenterol Hepatol. 2017 May;32(5):1100-1106. doi: 10.1111/jgh.13647.


Non-alcoholic fatty liver diseases and risk of colorectal neoplasia.

Ahn JS, Sinn DH, Min YW, Hong SN, Kim HS, Jung SH, Gu S, Rhee PL, Paik SW, Son HJ, Gwak GY.

Aliment Pharmacol Ther. 2017 Jan;45(2):345-353. doi: 10.1111/apt.13866. Epub 2016 Nov 18.


Long-term real-world entecavir therapy in treatment-naïve hepatitis B patients: base-line hepatitis B virus DNA and hepatitis B surface antigen levels predict virologic response.

Cho JY, Sohn W, Sinn DH, Gwak GY, Paik YH, Choi MS, Koh KC, Paik SW, Yoo BC, Lee JH.

Korean J Intern Med. 2017 Jul;32(4):636-646. doi: 10.3904/kjim.2016.096. Epub 2016 Nov 4.

Supplemental Content

Loading ...
Support Center